Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Linke

Showing results (361-370 of 444) with videos related to

Pageof 45
Sort By:
JAMA|February 9, 2021
Effect of High-Intensity Interval Training, Moderate Continuous Training, or Guideline-Based Physical Activity Advice on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical TrialStephan Mueller, Ephraim B Winzer, André Duvinage, et al.
Medicine and Science in Sports and Exercise|November 6, 2019
Baseline and Exercise Predictors of V˙O2peak in Systolic Heart Failure Patients: Results from SMARTEX-HFTrine Karlsen, Vibeke Videm, Martin Halle, et al.
European Heart Journal. Acute Cardiovascular Care|January 9, 2025
C-reactive protein levels and outcomes in infarct-related cardiogenic shock: data from the ECLS-SHOCK trialTobias Schupp, Holger Thiele, Tienush Rassaf, et al.
JACC. Cardiovascular Interventions|April 23, 2011
The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers TrialScot Garg, Patrick W Serruys, Sigmund Silber, et al.
Journal of the American College of Cardiology|May 28, 2011
The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention)Giulio G Stefanini, Patrick W Serruys, Sigmund Silber, et al.
Journal of Cardiac Failure|March 5, 2026
Microaxial Flow Pump Use in Different Phenotypes of Cardiogenic Shock - a Secondary Analysis of the DanGer Shock TrialElric Zweck, Rasmus P Beske, Christian Hassager, et al.
Circulation. Cardiovascular Interventions|January 12, 2026
Delay From First Symptoms in Patients Presenting With STEMI and Cardiogenic Shock: Insights From the DanGer Shock TrialLisette Okkels Jensen, Rasmus Paulin Beske, Hans Eiskjær, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 28, 2025
Prognostic impact of body mass index in acute myocardial infarction complicated by cardiogenic Shock: an ECLS-SHOCK subanalysisTobias Schupp, Holger Thiele, Tienush Rassaf, et al.
Nature Medicine|February 7, 2025
Telemedicine-supported lifestyle intervention for glycemic control in patients with CHD and T2DM: multicenter, randomized controlled trialStephan Mueller, Sophia M T Dinges, Felix Gass, et al.
European Journal of Preventive Cardiology|March 14, 2025
Effects of exercise training on nitric oxide metabolites in heart failure with reduced or preserved ejection fraction: a secondary analysis of the SMARTEX-HF and OptimEx-Clin trialsSophia Marie-Theres Dinges, Edzard Schwedhelm, Julia Schoenfeld, et al.
Pageof 45

Showing results (361-370 of 444) with videos related to

Sort By:
Pageof 45
JAMA|February 9, 2021
Effect of High-Intensity Interval Training, Moderate Continuous Training, or Guideline-Based Physical Activity Advice on Peak Oxygen Consumption in Patients With Heart Failure With Preserved Ejection Fraction: A Randomized Clinical TrialStephan Mueller, Ephraim B Winzer, André Duvinage, et al.
Medicine and Science in Sports and Exercise|November 6, 2019
Baseline and Exercise Predictors of V˙O2peak in Systolic Heart Failure Patients: Results from SMARTEX-HFTrine Karlsen, Vibeke Videm, Martin Halle, et al.
European Heart Journal. Acute Cardiovascular Care|January 9, 2025
C-reactive protein levels and outcomes in infarct-related cardiogenic shock: data from the ECLS-SHOCK trialTobias Schupp, Holger Thiele, Tienush Rassaf, et al.
JACC. Cardiovascular Interventions|April 23, 2011
The prognostic utility of the SYNTAX score on 1-year outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers TrialScot Garg, Patrick W Serruys, Sigmund Silber, et al.
Journal of the American College of Cardiology|May 28, 2011
The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutaneous coronary intervention)Giulio G Stefanini, Patrick W Serruys, Sigmund Silber, et al.
Journal of Cardiac Failure|March 5, 2026
Microaxial Flow Pump Use in Different Phenotypes of Cardiogenic Shock - a Secondary Analysis of the DanGer Shock TrialElric Zweck, Rasmus P Beske, Christian Hassager, et al.
Circulation. Cardiovascular Interventions|January 12, 2026
Delay From First Symptoms in Patients Presenting With STEMI and Cardiogenic Shock: Insights From the DanGer Shock TrialLisette Okkels Jensen, Rasmus Paulin Beske, Hans Eiskjær, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|July 28, 2025
Prognostic impact of body mass index in acute myocardial infarction complicated by cardiogenic Shock: an ECLS-SHOCK subanalysisTobias Schupp, Holger Thiele, Tienush Rassaf, et al.
Nature Medicine|February 7, 2025
Telemedicine-supported lifestyle intervention for glycemic control in patients with CHD and T2DM: multicenter, randomized controlled trialStephan Mueller, Sophia M T Dinges, Felix Gass, et al.
European Journal of Preventive Cardiology|March 14, 2025
Effects of exercise training on nitric oxide metabolites in heart failure with reduced or preserved ejection fraction: a secondary analysis of the SMARTEX-HF and OptimEx-Clin trialsSophia Marie-Theres Dinges, Edzard Schwedhelm, Julia Schoenfeld, et al.
Pageof 45